BCHE and Alzheimer disease: Current pharmacologic treatments for AD are three cholinesterase inhibitors (donepezil, rivastigmine, and galantamine), one N-methyl-D-aspartate (NMDA) receptor antagonist (memantine), and two DMT anti-Aβ antibody drugs (aducanumab and lecanemab).